牙周炎与口腔黏膜病相关性的研究进展
|
摘要
牙周炎不仅影响牙周健康,也与一些累及牙龈部位的口腔黏膜疾病有关。一方面由于黏膜病变的存在,在局部口腔卫生欠佳的影响下会加重牙周炎症,影响牙周病变的进展。另一方面,二者在微生物和免疫的病因机制上也存在相互作用。本文就牙周炎与口腔扁平苔藓、天疱疮、类天疱疮和口腔白斑等常见的口腔黏膜病的相关性研究进展作一综述。
引文
[1] Michaud DS,Fu Z,Shi J,et al.Periodontal disease,tooth loss,and cancer risk[J/OL].Epidemiol Rev,2017,39(1):49-58[2019-01-30].https://doi.org/10.1093/epirev/mxx006.
[2] Cruchley AT,Bergmeier LA.Oral Mucosa in Health and Disease[M].Cham:Springer,2018:1-18.
[3] Alrashdan MS,Cirillo N,McCullough M.Oral lichen planus:a literature review and update[J/OL].Arch Dermatol Res,2016,308(8):539-551[2019-01-30].https://doi.org/10.1007/s00403-016-1667-2.
[4] Rai NP,Kumar P,Mustafa SM,et al.Relation between periodontal status and pre-cancerous condition (oral lichen planus):a pilot study[J/OL].Adv Clin Exp Med,2016,25(4):763-766[2019-01-30].https://doi.org/10.17219/acem/59014.
[5] Azizi A,Rezaee M.Comparison of periodontal status in gingival oral lichen planus patients and healthy subjects[J/OL].Dermatol Res Pract,2012,2012:561232[2019-01-30].https://doi.org/10.1155/2012/561232.
[6] Sakall?-?ak?ak D,Akman-Karaka? A,Tosun O,et al.Relation-ship between periodontal findings and oral lichen planus:a controlled study[J].Dentistry Adv Res,2016,2016:G111.
[7] Ertugrul AS,Arslan U,Dursun R,et al.Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis[J/OL].Int J Oral Sci,2013,5(2):92-97[2019-01-30].https://doi.org/10.1038/ijos.2013.30.
[8] Zeng Q,Yang X,Chen X,et al.Porphyromonas gingivalis lipopolysaccharide induces over production of CC chemokine ligand 2 via toll-like receptor-4 in oral lichen planus[J/OL].J Oral Pathol Med,2018,47(2):166-172[2019-01-30].https://doi.org/10.1111/jop.12655.
[9] Ertugrul AS,Dursun R,Dundar N,et al.MMP-1,MMP-9,and TIMP-1 levels in oral lichen planus patients with ginivitis or periodontitis[J/OL].Arch Oral Biol,2013,58(7):843-852[2019-01-30].https://doi.org/10.1016/j.archoralbio.2013.01.015.
[10] Wang H,Han Q,Luo Z,et al.Oral lichen planus may enhance the expression of Th17-associated cytokines in local lesions of chronic periodontitis[J/OL].Clin Oral Investig,2014,18(6):1647-1654[2019-01-30].https://doi.org/10.1007/s00784-013-1131-z.
[11] Davari P,Hsiao HH,Fazel N.Mucosal lichen planus:an evidence-based treatment update[J/OL].Am J Clin Dermatol,2014,15(3):181-195[2019-01-30].https://doi.org/10.1007/s40257-014-0068-6.
[12] Stone SJ,Heasman PA,Staines KS,et al.The impact of structured plaque control for patients with gingival manifestations of oral lichen planus:a randomized controlled study[J/OL].J Clin Periodontol,2015,42(4):356-362[2019-01-30].https://doi.org/10.1111/jcpe.12385.
[13] Salgado DS,Jeremias F,Capela MV,et al.Plaque control improves the painful symptoms of oral lichen planus gingival lesions.A short-term study.[J/OL].J Oral Pathol Med,2013,42(10):728-732[2019-01-30].https://doi.org/10.1111/jop.12093.
[14] Winning L,Willis A,Mullally B,et al.Desquamative gingivitis-aetiology,diagnosis and management[J].Dent Update,2017,44(6):564-570.
[15] Romano F,Arduino PG,Maggiora M,et al.Effect of a structured plaque control on MMP-1 and MMP-9 crevicular levels in patients with desquamative gingivitis associated with oral lichen planus[J/OL].Clin Oral Investig,2018,:1-8[2019-01-30].https://doi.org/10.1007/s00784-018-2704-7.
[16] Schmidt E,Goebeler M,Hertl M,et al.S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid[J/OL].J Dtsch Dermatol Ges,2015,13(7):713-727[2019-01-30].https://doi.org/10.1111/ddg.12612.
[17] Endo H,Rees T,Niwa H,et al.Desquamative gingivitis:early sign of autoimmune bullous diseases[M]//Periodontology.IntechOpen,2018.
[18] Lo Russo L,Gallo C,Pellegrino G,et al.Periodontal clinical and microbiological data in desquamative gingivitis patients[J/OL].Clin Oral Investig,2014,18(3):917-925[2019-01-30].https://doi.org/10.1007/s00784-013-1038-8.
[19] Jascholt I,Lai O,Zillikens D,et al.Periodontitis in oral pemphigus and pemphigoid:A systematic review of published studies[J/OL].J Am Acad Dermatol,2017,76(5):975-978[2019-01-30].https://doi.org/10.1016/j.jaad.2016.10.028.
[20] Yucel-Lindberg T,B?ge T.Inflammatory mediators in the pathogenesis of periodontitis[J/OL].Expert Rev Mol Med,2013,15:e7[2019-01-30].https://doi.org/10.1017/erm.2013.8.
[21] Schmidt E,Zillikens D.Pemphigoid diseases[J/OL].Lancet,2013,381(9863):320-332[2019-01-30].https://doi.org/10.1016/S0140-6736(12)61140-4.
[22] Hajishengallis G.Periodontitis:from microbial immune subversion to systemic inflammation[J/OL].Nat Rev Immunol,2015,15(1):30-44[2019-01-30].https://doi.org/10.1038/nri3785.
[23] Gillenwater AM,Vigneswaran N,Fatani H,et al.Proliferative verrucous leukoplakia:recognition and differentiation from conventional leukoplakia and mimics[J/OL].Head Neck,2014,36(11):1662-1668 https://doi.org/10.1002/hed.23505.
[24] Galv?o-Moreira LV,da Cruz MC.Oral microbiome,periodontitis and risk of head and neck cancer[J/OL].Oral oncology,2016,53:17-19[2019-01-30].https://doi.org/10.1016/j.oraloncology.2015.11.013.
[25] Javed F,Warnakulasuriya S.Is there a relationship between periodontal disease and oral cancer?A systematic review of currently available evidence[J/OL].Crit Rev Oncol Hematol,2016,97:197-205[2019-01-30].https://doi.org/10.1016/j.critrevonc.2015.08.018.
[26] Crusz SM,Balkwill FR.Inflammation and cancer:advances and new agents[J/OL].Nat Rev Clin Oncol,2015,12(10):584-596 https://doi.org/10.1038/nrclinonc.2015.105.
[27] Ahn J,Chen CY,Hayes RB.Oral microbiome and oral and gastrointestinal cancer risk[J/OL].Cancer Causes Control,2012,23(3):399-404[2019-01-30].https://doi.org/10.1007/s10552-011-9892-7.
[28] Elkaim R,Bugueno-Valdebenito IM,Benkirane-Jessel N,et al.Porphyromonas gingivalis and its lipopolysaccharide differently modulate epidermal growth factor–dependent signaling in human gingival epithelial cells[J/OL].J Oral Microbiol,2017,9(1):1334503-[2019-01-30].https://doi.org/10.1080/20002297.2017.1334503.
[29] Sahingur SE,Yeudall WA.Chemokine function in periodontal disease and oral cavity cancer[J/OL].Front Immunol,2015,6:214[2019-01-30].https://doi.org/10.3389/fimmu.2015.00214.
[2] Cruchley AT,Bergmeier LA.Oral Mucosa in Health and Disease[M].Cham:Springer,2018:1-18.
[3] Alrashdan MS,Cirillo N,McCullough M.Oral lichen planus:a literature review and update[J/OL].Arch Dermatol Res,2016,308(8):539-551[2019-01-30].https://doi.org/10.1007/s00403-016-1667-2.
[4] Rai NP,Kumar P,Mustafa SM,et al.Relation between periodontal status and pre-cancerous condition (oral lichen planus):a pilot study[J/OL].Adv Clin Exp Med,2016,25(4):763-766[2019-01-30].https://doi.org/10.17219/acem/59014.
[5] Azizi A,Rezaee M.Comparison of periodontal status in gingival oral lichen planus patients and healthy subjects[J/OL].Dermatol Res Pract,2012,2012:561232[2019-01-30].https://doi.org/10.1155/2012/561232.
[6] Sakall?-?ak?ak D,Akman-Karaka? A,Tosun O,et al.Relation-ship between periodontal findings and oral lichen planus:a controlled study[J].Dentistry Adv Res,2016,2016:G111.
[7] Ertugrul AS,Arslan U,Dursun R,et al.Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis[J/OL].Int J Oral Sci,2013,5(2):92-97[2019-01-30].https://doi.org/10.1038/ijos.2013.30.
[8] Zeng Q,Yang X,Chen X,et al.Porphyromonas gingivalis lipopolysaccharide induces over production of CC chemokine ligand 2 via toll-like receptor-4 in oral lichen planus[J/OL].J Oral Pathol Med,2018,47(2):166-172[2019-01-30].https://doi.org/10.1111/jop.12655.
[9] Ertugrul AS,Dursun R,Dundar N,et al.MMP-1,MMP-9,and TIMP-1 levels in oral lichen planus patients with ginivitis or periodontitis[J/OL].Arch Oral Biol,2013,58(7):843-852[2019-01-30].https://doi.org/10.1016/j.archoralbio.2013.01.015.
[10] Wang H,Han Q,Luo Z,et al.Oral lichen planus may enhance the expression of Th17-associated cytokines in local lesions of chronic periodontitis[J/OL].Clin Oral Investig,2014,18(6):1647-1654[2019-01-30].https://doi.org/10.1007/s00784-013-1131-z.
[11] Davari P,Hsiao HH,Fazel N.Mucosal lichen planus:an evidence-based treatment update[J/OL].Am J Clin Dermatol,2014,15(3):181-195[2019-01-30].https://doi.org/10.1007/s40257-014-0068-6.
[12] Stone SJ,Heasman PA,Staines KS,et al.The impact of structured plaque control for patients with gingival manifestations of oral lichen planus:a randomized controlled study[J/OL].J Clin Periodontol,2015,42(4):356-362[2019-01-30].https://doi.org/10.1111/jcpe.12385.
[13] Salgado DS,Jeremias F,Capela MV,et al.Plaque control improves the painful symptoms of oral lichen planus gingival lesions.A short-term study.[J/OL].J Oral Pathol Med,2013,42(10):728-732[2019-01-30].https://doi.org/10.1111/jop.12093.
[14] Winning L,Willis A,Mullally B,et al.Desquamative gingivitis-aetiology,diagnosis and management[J].Dent Update,2017,44(6):564-570.
[15] Romano F,Arduino PG,Maggiora M,et al.Effect of a structured plaque control on MMP-1 and MMP-9 crevicular levels in patients with desquamative gingivitis associated with oral lichen planus[J/OL].Clin Oral Investig,2018,:1-8[2019-01-30].https://doi.org/10.1007/s00784-018-2704-7.
[16] Schmidt E,Goebeler M,Hertl M,et al.S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid[J/OL].J Dtsch Dermatol Ges,2015,13(7):713-727[2019-01-30].https://doi.org/10.1111/ddg.12612.
[17] Endo H,Rees T,Niwa H,et al.Desquamative gingivitis:early sign of autoimmune bullous diseases[M]//Periodontology.IntechOpen,2018.
[18] Lo Russo L,Gallo C,Pellegrino G,et al.Periodontal clinical and microbiological data in desquamative gingivitis patients[J/OL].Clin Oral Investig,2014,18(3):917-925[2019-01-30].https://doi.org/10.1007/s00784-013-1038-8.
[19] Jascholt I,Lai O,Zillikens D,et al.Periodontitis in oral pemphigus and pemphigoid:A systematic review of published studies[J/OL].J Am Acad Dermatol,2017,76(5):975-978[2019-01-30].https://doi.org/10.1016/j.jaad.2016.10.028.
[20] Yucel-Lindberg T,B?ge T.Inflammatory mediators in the pathogenesis of periodontitis[J/OL].Expert Rev Mol Med,2013,15:e7[2019-01-30].https://doi.org/10.1017/erm.2013.8.
[21] Schmidt E,Zillikens D.Pemphigoid diseases[J/OL].Lancet,2013,381(9863):320-332[2019-01-30].https://doi.org/10.1016/S0140-6736(12)61140-4.
[22] Hajishengallis G.Periodontitis:from microbial immune subversion to systemic inflammation[J/OL].Nat Rev Immunol,2015,15(1):30-44[2019-01-30].https://doi.org/10.1038/nri3785.
[23] Gillenwater AM,Vigneswaran N,Fatani H,et al.Proliferative verrucous leukoplakia:recognition and differentiation from conventional leukoplakia and mimics[J/OL].Head Neck,2014,36(11):1662-1668 https://doi.org/10.1002/hed.23505.
[24] Galv?o-Moreira LV,da Cruz MC.Oral microbiome,periodontitis and risk of head and neck cancer[J/OL].Oral oncology,2016,53:17-19[2019-01-30].https://doi.org/10.1016/j.oraloncology.2015.11.013.
[25] Javed F,Warnakulasuriya S.Is there a relationship between periodontal disease and oral cancer?A systematic review of currently available evidence[J/OL].Crit Rev Oncol Hematol,2016,97:197-205[2019-01-30].https://doi.org/10.1016/j.critrevonc.2015.08.018.
[26] Crusz SM,Balkwill FR.Inflammation and cancer:advances and new agents[J/OL].Nat Rev Clin Oncol,2015,12(10):584-596 https://doi.org/10.1038/nrclinonc.2015.105.
[27] Ahn J,Chen CY,Hayes RB.Oral microbiome and oral and gastrointestinal cancer risk[J/OL].Cancer Causes Control,2012,23(3):399-404[2019-01-30].https://doi.org/10.1007/s10552-011-9892-7.
[28] Elkaim R,Bugueno-Valdebenito IM,Benkirane-Jessel N,et al.Porphyromonas gingivalis and its lipopolysaccharide differently modulate epidermal growth factor–dependent signaling in human gingival epithelial cells[J/OL].J Oral Microbiol,2017,9(1):1334503-[2019-01-30].https://doi.org/10.1080/20002297.2017.1334503.
[29] Sahingur SE,Yeudall WA.Chemokine function in periodontal disease and oral cavity cancer[J/OL].Front Immunol,2015,6:214[2019-01-30].https://doi.org/10.3389/fimmu.2015.00214.